KR20240159852A - 감염성 질환을 치료하기 위한 새로운 방법 - Google Patents

감염성 질환을 치료하기 위한 새로운 방법 Download PDF

Info

Publication number
KR20240159852A
KR20240159852A KR1020247034395A KR20247034395A KR20240159852A KR 20240159852 A KR20240159852 A KR 20240159852A KR 1020247034395 A KR1020247034395 A KR 1020247034395A KR 20247034395 A KR20247034395 A KR 20247034395A KR 20240159852 A KR20240159852 A KR 20240159852A
Authority
KR
South Korea
Prior art keywords
peptide
angptl4
protein
amino acid
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247034395A
Other languages
English (en)
Korean (ko)
Inventor
상드린 부르두루
자종 지베리
로익 르 궈넥
Original Assignee
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔)
위니베르시떼 빠리 시테
상뜨로 나쇼날 드 라 러쉐르쉐 샹띠피크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔), 위니베르시떼 빠리 시테, 상뜨로 나쇼날 드 라 러쉐르쉐 샹띠피크 filed Critical 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔)
Publication of KR20240159852A publication Critical patent/KR20240159852A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020247034395A 2022-03-16 2023-03-15 감염성 질환을 치료하기 위한 새로운 방법 Pending KR20240159852A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22305312 2022-03-16
EP22305312.5 2022-03-16
PCT/EP2023/056642 WO2023175022A1 (en) 2022-03-16 2023-03-15 New method to treat infectious diseases

Publications (1)

Publication Number Publication Date
KR20240159852A true KR20240159852A (ko) 2024-11-06

Family

ID=81324956

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247034395A Pending KR20240159852A (ko) 2022-03-16 2023-03-15 감염성 질환을 치료하기 위한 새로운 방법

Country Status (6)

Country Link
US (1) US20250163116A1 (https=)
EP (1) EP4493590A1 (https=)
JP (1) JP2025512749A (https=)
KR (1) KR20240159852A (https=)
CN (1) CN119053620A (https=)
WO (1) WO2023175022A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023219197A1 (en) * 2022-02-14 2024-08-22 Sumant Singh CHUGH Methods of treating a cytokine storm related disease with recombinant mutated human angiopoietin-like 4
WO2025247922A1 (en) * 2024-05-28 2025-12-04 Institut National de la Santé et de la Recherche Médicale Use of the recombinant fibrinogen-like domain of angiopoietin-like 4 for treating sepsis capillary leak syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
WO1991018982A1 (en) 1990-06-05 1991-12-12 Immunex Corporation Type ii interleukin-1 receptors
US6074849A (en) 1995-07-19 2000-06-13 Genetics Institute, Inc. Polynucleotides encoding human CTLA-8 related proteins
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
FR2827866B1 (fr) 2001-07-27 2004-12-10 Pasteur Institut Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations
WO2004011595A2 (fr) 2002-07-26 2004-02-05 Institut Pasteur Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
WO2011080132A2 (en) 2009-12-17 2011-07-07 Katholieke Universiteit Leuven, K.U. Leuven R&D Compounds, compositions and methods for controlling biofilms
WO2016020880A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoietin-like 4 antibodies and methods of use
WO2016020882A2 (en) * 2014-08-07 2016-02-11 Novartis Ag Angiopoetin-like 4 (angptl4) antibodies and methods of use
US11446398B2 (en) * 2016-04-11 2022-09-20 Obsidian Therapeutics, Inc. Regulated biocircuit systems

Also Published As

Publication number Publication date
EP4493590A1 (en) 2025-01-22
JP2025512749A (ja) 2025-04-22
US20250163116A1 (en) 2025-05-22
WO2023175022A1 (en) 2023-09-21
CN119053620A (zh) 2024-11-29

Similar Documents

Publication Publication Date Title
US20240092867A1 (en) Methods and compositions for the treatment of wounds
KR20240159852A (ko) 감염성 질환을 치료하기 위한 새로운 방법
US20160213760A1 (en) Aprotinin-derived polypeptide-antibody conjugates
JP6158097B2 (ja) 炎症を抑制するためのペプチド
JP7384672B2 (ja) Ｃ末端ｃｄｎｆ断片及びｃ末端ｍａｎｆ断片、それらを含む医薬組成物、並びにそれらの使用
JP7641025B2 (ja) 神経損傷及び関連障害を治療するための方法
JP7792115B2 (ja) 感染症及び関連炎症プロセスの処置のための細菌結合ペプチド
IL296628A (en) Ngr conjugates and uses thereof
JP2020169162A (ja) 合成ペプチド、それを備える薬学的組成物及び血栓塞栓症関連疾患の治療におけるその使用
US12479895B2 (en) C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof
US20230374091A1 (en) Annexin a5 compositions and methods
US20230167162A1 (en) Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa
KR20210151188A (ko) 뼈 및 관절 감염증의 치료 및 예방 방법
KR20210141667A (ko) 감염성 심내막염의 치료 방법
US20250352614A1 (en) Peptide therapeutics for the treatment of cancer and uses thereof
TWI875927B (zh) 一種治療神經損傷及其相關病症的方法
WO2025049979A1 (en) Hydrophobically interspaced charged peptides for preventing or treating apoe and/or amyloid beta pathologic interaction in alzheimer's disease and related dementias
CN115209912A (zh) 肽组合物及其使用方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20241015

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application